Optiflow™
nasal high flow therapy

Proven respiratory support

Used as a first-line treatment across the care continuum, Optiflow NHF may reduce patient escalation resulting in better clinical outcomes.
Upcoming EIA webinar - RSV, COVID-19, influenza.
Delivering Optiflow therapy (equip. guide)
NHF practice guidelines & recommendations

While many terms describe nasal high flow therapy (aka HFNC), one stands out. Optiflow NHF therapy. 

Optiflow is at the forefront of its field, featuring in hundreds of publications in journals such as NEJM and JAMA. 
 

EVIDENCE IN ACTION WEBINAR

How can nasal high flow support your management of the triple threat (RSV, COVID-19 and influenza)?

Wednesday, December 14, 2022,
at 8am (PST), 10am (CST) and 11am (EST)
 
Granville Health Research Director James Neuenschwander, MD, FACEP, FASAM, presents this must-attend free webinar for healthcare workers preparing to combat the trio of respiratory viruses on the wards this season.

Register now

 

Published guidelines highlight the breadth of application of NHF




Hundreds of randomized controlled trials have been consolidated into evidence-based clinical practice guidelines. 

These guidelines underscore the breadth of application of nasal high flow therapy.
 

We’ve created a table that will help you review the  guidelines by patient population and application.

 

Explore the NHF guidelines table

Flow Matters newsletter 

Hundreds of publications per year are being consolidated into practice guidelines and providing insights into new applications of NHF therapy. 

Flow Matters keeps you up-to-date with this ever-evolving field of research. Subscribe to Flow Matters here. 
Flow matters Pediatric edition - updated Sept. 2022
 

Updated September 2022
 


Early use of NHF in infants and children


In this edition we review the literature and provide an evidence-based approach to implementation of NHF in pediatric patients.


Read now

 

Optiflow NHF therapy FAQs

Explore our frequently asked questions regarding:

1. Clinical practice/implementaion of NHF therapy. 
2. Published evidence - the science of high-flow therapy, including the mechanisms of action and patient outcomes.  

 
Search Optiflow FAQs
 


 

Watch Optiflow NHF therapy in practice

Optiflow NHF therapy across the care continuum

 
  • This video shows the introduction of the Airvo 2 device across departments of the Royal Berkshire Hospital in Reading, UK.
  • Hospital clinicians talk about the benefits found both to the patients and hospital since its introduction. 
 
 

Extubation to Optiflow NHF therapy: Dr. Hernández

 
 
 

Options for delivering Optiflow NHF therapy

Did you know there are several ways to deliver/get the benefits of Optiflow nasal high flow therapy. 

1. You can use a dedicated, standalone device such as the Airvo Optiflow system or
2. You can use an NHF-capable mechanical ventilator. We call this a vent-driven system. 

See the images below and for more details download our equipment guide. 

Airvo Optiflow NHF system

The following figure demonstrates what is required for an Airvo Optiflow system.  

Vent-driven Optiflow High Flow system

The following figure demonstrates what is required to enable your NHF-capable mechanical ventilator to form part of a vent-driven Optiflow system.
 

Call us

1800 446 3908 / +1949 453 4000


or get in touch by email, using the form below 

 

Enquire about Optiflow nasal high flow therapy
If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.
Enter security code:*
 Security code